Chimerix Statistics
Total Valuation
Chimerix has a market cap or net worth of $80.66 million. The enterprise value is -$77.37 million.
| Market Cap | 80.66M |
| Enterprise Value | -77.37M |
Important Dates
The next estimated earnings date is Thursday, August 1, 2024, before market open.
| Earnings Date | Aug 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Chimerix has 89.63 million shares outstanding. The number of shares has increased by 1.09% in one year.
| Shares Outstanding | 89.63M |
| Shares Change (YoY) | +1.09% |
| Shares Change (QoQ) | +0.39% |
| Owned by Insiders (%) | 6.65% |
| Owned by Institutions (%) | 47.82% |
| Float | 74.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 1.21 |
| PS Ratio | 1,967.27 |
| Forward PS | n/a |
| PB Ratio | 0.46 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.61, with a Debt / Equity ratio of 0.01.
| Current Ratio | 8.61 |
| Quick Ratio | 8.40 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -41.30% and return on invested capital (ROIC) is -53.25%.
| Return on Equity (ROE) | -41.30% |
| Return on Assets (ROA) | -37.80% |
| Return on Capital (ROIC) | -53.25% |
| Revenue Per Employee | $569 |
| Profits Per Employee | -$1.15M |
| Employee Count | 72 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.63% in the last 52 weeks. The beta is 1.19, so Chimerix's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | -25.63% |
| 50-Day Moving Average | 0.92 |
| 200-Day Moving Average | 0.98 |
| Relative Strength Index (RSI) | 50.25 |
| Average Volume (20 Days) | 235,509 |
Short Selling Information
The latest short interest is 1.81 million, so 2.02% of the outstanding shares have been sold short.
| Short Interest | 1.81M |
| Short Previous Month | 1.33M |
| Short % of Shares Out | 2.02% |
| Short % of Float | 2.42% |
| Short Ratio (days to cover) | 7.88 |
Income Statement
In the last 12 months, Chimerix had revenue of $41,000 and -$82.59 million in losses. Loss per share was -$0.94.
| Revenue | 41,000 |
| Gross Profit | 41,000 |
| Operating Income | -93.24M |
| Pretax Income | -82.59M |
| Net Income | -82.59M |
| EBITDA | -82.60M |
| EBIT | -82.59M |
| Loss Per Share | -$0.94 |
Balance Sheet
The company has $159.03 million in cash and $1.01 million in debt, giving a net cash position of $158.02 million or $1.76 per share.
| Cash & Cash Equivalents | 159.03M |
| Total Debt | 1.01M |
| Net Cash | 158.02M |
| Net Cash Per Share | $1.76 |
| Equity (Book Value) | 174.10M |
| Book Value Per Share | 1.94 |
| Working Capital | 144.10M |
Cash Flow
In the last 12 months, operating cash flow was -$64.38 million and capital expenditures -$46,000, giving a free cash flow of -$64.43 million.
| Operating Cash Flow | -64.38M |
| Capital Expenditures | -46,000 |
| Free Cash Flow | -64.43M |
| FCF Per Share | -$0.72 |
Margins
Gross margin is 100.00%, with operating and profit margins of -227,407.32% and -201,443.90%.
| Gross Margin | 100.00% |
| Operating Margin | -227,407.32% |
| Pretax Margin | -201,443.90% |
| Profit Margin | -201,443.90% |
| EBITDA Margin | -201,453.66% |
| EBIT Margin | -201,443.90% |
| FCF Margin | -157,139.02% |
Dividends & Yields
Chimerix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.09% |
| Shareholder Yield | -1.09% |
| Earnings Yield | -102.40% |
| FCF Yield | -79.88% |
Analyst Forecast
The average price target for Chimerix is $8.50, which is 844.55% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.50 |
| Price Target Difference | 844.55% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 279.55% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Chimerix has an Altman Z-Score of -3.98 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.98 |
| Piotroski F-Score | 3 |